TSW
WST icon

Thompson Siegel & Walmsley’s West Pharmaceutical WST Stock Holding History

Thompson Siegel & Walmsley’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-26
Closed -$9K – 748
2021
Q2 		$9K Buy
+26
New +$8.59K ﹤0.01% 662

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Thompson Siegel & Walmsley's WST Position: Q3 2021 in Review

Thompson Siegel & Walmsley sold out of West Pharmaceutical (WST) in Q3 2021, closing a stake of 26 shares — an estimated $9K sold.

Thompson Siegel & Walmsley first reported a position in WST in Q2 2021 and held it in 1 quarter. The position peaked at $9K in Q2 2021. 669 funds tracked by Wall St. Rank hold WST as of Q3 2021.

  • Thompson Siegel & Walmsley reported no remaining West Pharmaceutical position as of Q3 2021 after selling out during the quarter.
  • Thompson Siegel & Walmsley sold 26 West Pharmaceutical shares in Q3 2021, an estimated $9K.
  • Thompson Siegel & Walmsley first reported a position in West Pharmaceutical in Q2 2021 and held it in 1 quarter.
  • Thompson Siegel & Walmsley's West Pharmaceutical position peaked at $9K in Q2 2021.
  • 669 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2021.

Based on Thompson Siegel & Walmsley's 13F filing for Q3 2021, filed 5 Nov 2021.